4//SEC Filing
Walker Luke Nathaniel 4
Accession 0001209191-22-052200
CIK 0001708493other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:12 PM ET
Size
5.9 KB
Accession
0001209191-22-052200
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-10-03+305,000→ 305,000 totalExercise: $1.08Exp: 2032-10-02→ Common Stock (305,000 underlying)
Footnotes (2)
- [F1]The stock option was granted pursuant to the Issuer's 2022 Inducement Plan.
- [F2]1/4th of the total stock option will vest and become exercisable on the first anniversary of the vesting commencement date of October 3, 2022 ("VCD"), and 1/36th of the remaining stock option will vest and become exercisable monthly on the same day of each month following the VCD, subject to the continued service of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001701440
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:12 PM ET
- Size
- 5.9 KB